Calumet, Inc. reported Q2 2026 adjusted EBITDA of $175M, exceeding consensus. Specialty products segment drives growth with $161.7M in EBITDA. Deleveraging efforts accelerate.
Calumet, Inc. reported Q2 2026 adjusted EBITDA of $175 million, significantly above the consensus of $150 million. This robust performance was driven by strong demand in the specialty products segment, alongside a strategic focus on deleveraging and capital-efficient growth initiatives.
Key Takeaways
- Adjusted EBITDA reached $175 million, exceeding the $150 million consensus, reflecting strong operational execution despite planned turnaround activities.
- Specialty products segment generated $161.7 million in adjusted EBITDA, more than double the prior year, driven by over 20 successful price increases.
- Montana Renewables contributed $17 million in adjusted EBITDA even with downtime for expansion, highlighting strong underlying market dynamics for biodiesel.
- Leverage ratio fell below 4 times, with expectations to drop below 3 times in the next quarter as the company continues its accelerated debt reduction.
- Cash flow from operations was over $90 million, supported by higher specialty product prices and effective working capital management.
Strong Performance Amid Turnaround Activities
Calumet's adjusted EBITDA of $175 million marked a strong rebound from the previous year, driven by both its specialty products and Montana Renewables segments. The company's specialty products segment achieved adjusted EBITDA of $161.7 million, more than double that of the prior year. This surge is attributed to over 20 price increases that have fully materialized, supported by solid operational execution during a quarter that included three planned turnarounds.
| Metric | Q2 2026 | YoY | QoQ |
|---|---|---|---|
| Adjusted EBITDA | $175M | +35% | +10% |
| Specialty Products EBITDA | $161.7M | +105% | +20% |
| Montana Renewables EBITDA | $17M | N/A | N/A |
| Cash Flow from Operations | $90M | N/A | N/A |
Specialty Products Segment Drives Growth
The specialty products segment outperformed expectations, generating $161.7 million in adjusted EBITDA, more than double the previous year. Management noted that this performance was bolstered by a series of successful price increases and robust demand across its portfolio. The company maintained sales volume above 20,000 barrels per day for the seventh consecutive quarter, indicating strong operational momentum.
Todd Borgman, CEO, remarked, >"Our integrated specialty strategy is proving effective, as evidenced by our ability to capitalize on favorable market dynamics stemming from global supply disruptions."
Montana Renewables Sustains Positive Momentum
Montana Renewables also showed promising results, contributing $17 million to adjusted EBITDA despite facing downtime due to expansion activities. The segment benefited from favorable Renewable Volume Obligation (RVO) dynamics, leading to a sharp increase in biodiesel margins. Management indicated that the company is on track to significantly ramp up production as new facilities come online, with expectations for a meaningful increase in EBITDA in the upcoming quarters.
The anticipated completion of the MAX SAF150 expansion is expected to facilitate a production run rate of 60 million gallons of sustainable aviation fuel (SAF) by early next year, with the potential to reach 200 million gallons by 2028.
Accelerated Deleveraging Efforts
Calumet's focus on deleveraging has yielded results, with the company reducing its leverage ratio below 4 times, and management forecasting a drop below 3 times as early as next quarter. The company has been proactive in managing its debt, having recently called $100 million of notes and retired a sale leaseback on a truck rack. This strategic focus on debt reduction is expected to enhance financial flexibility and support future growth initiatives.
David Lunan, CFO, stated, >"We are committed to an accelerated pace of deleveraging, and our strong cash flow positions us well to continue reducing our debt while investing in high-return growth opportunities."
Analyst Q&A Highlights
During the Q&A session, management addressed questions regarding the durability of high base oil margins amidst ongoing global disruptions. Scott Obermeyer, President of Specialties, emphasized that the market remains tight due to significant capacity disruptions, particularly in the Middle East and Europe, which would likely sustain favorable pricing dynamics for the foreseeable future.
When asked about the potential monetization of Montana Renewables, management clarified that while they remain committed to optimizing shareholder value, they do not need to pursue monetization as a prerequisite for growth. Instead, the focus will shift to utilizing strong operational cash flows for strategic initiatives.
Frequently Asked Questions
Did Calumet, Inc. Common Stock beat earnings estimates in Q2 2026?
Yes, Calumet reported an adjusted EBITDA of $175 million, exceeding the consensus estimate of $150 million.
What were the key drivers of Calumet’s Q2 2026 performance?
The strong performance was primarily driven by the specialty products segment, which achieved $161.7 million in adjusted EBITDA, supported by successful price increases and high production volumes.
How did Montana Renewables perform in Q2 2026?
Montana Renewables contributed $17 million in adjusted EBITDA despite operational downtime, benefiting from favorable market conditions and the ongoing expansion project.
What is Calumet’s outlook for debt reduction?
Calumet expects its leverage ratio to fall below 3 times in the next quarter as it continues its accelerated debt reduction strategy, supported by strong cash flows.
What is the expected impact of the MAX SAF150 expansion?
The MAX SAF150 expansion is anticipated to increase production capacity significantly, with expectations of a 60 million gallon run rate for SAF by early next year, potentially reaching 200 million gallons by 2028.
In conclusion, Calumet enters the second half of 2026 with strong operational momentum and a clear focus on continued debt reduction and strategic growth initiatives. The combination of a favorable market environment for specialty products and a disciplined approach to capital allocation positions the company well for sustained performance.
This analysis is based on public earnings call materials and is not investment advice.
